A quick search across the web will bring up results stating All IGF 1 lr3 Is FAKE and sadly this is far from the truth
But it's also more expensive and can cause more side effects
The aim of this study was to assess whether semaglutide, versus placebo, improves glycemic control and other nonglycemic outcomes in those with T1D while using AID
Landmark trials include STEP (semaglutide for weight management, NEJM 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
We encourage you to engage actively with our healthcare professionals, ask questions, and express any concerns
After your purchase, you should be able to download your digital downloads